GlassScriptPhysician profile
Sandip Saha
NPI 1942563911
$5,068.43
in general payments reported to CMS, 2019-2025
10 companies · $606 in 2025
The $606 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,407 · 2022: $15.98 · 2024: $2,039 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712 · Travel and Lodging: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.02 |
| Travel and Lodging | $933.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $1,327.12 | 2024-2025 | Aliya System |
| Olympus Corporation of The Americas | $1,229.40 | 2019 | |
| Pinnacle Biologics, INC | $1,177.99 | 2019 | |
| Medical Device Business Services, INC. | $1,049.51 | 2024 | Monarch |
| Astrazeneca Pharmaceuticals LP | $110.01 | 2024 | Imfinzi |
| Olympus America INC. | $69.40 | 2025 | |
| Pulmonx Corporation | $38.00 | 2024 | Zephyr Endobronchial Valve |
| Eisai INC. | $29.57 | 2025 | Lenvima |
| Janssen Biotech, INC. | $21.45 | 2025 | Tremfya |
| Siemens Medical Solutions USA, INC. | $15.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandip Saha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.